跳至主要内容
临床试验/NL-OMON34213
NL-OMON34213已完成2 期

Botulinum toxin as a new treatment modality for jerky psychogenic movement disorders: a monocenter randomized controlled trial - Botulinum neurotoxin as treatment in psychogenic jerks

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Eligible patients for the study have at least one consistent type of jerk of psychogenic origin. Two movement disorder specialists have to agree on the diagnosis based on clinical characteristics and on additional investigations if considered necessary. The diagnosis of psychogenic jerks needs to have a *definite* or *probable* level of certainty for psychogenic movement disorders. The jerk of interest has to significantly disable the patient in his/her daily functioning according to the patient and the movement disorder specialists and needs to be performed by a muscle or muscles amendable to injection. The jerk of interest may be simple or complex if only treatment with BoNT is considered possible.

排除标准

  • * Age < 18 years or > 80 years;
  • * Psychogenic jerk of interest present for < 1 year;
  • * Previous or current treatment with BoNT;
  • * Legally incompetent adult;
  • * Pregnancy;
  • * Coagulation disorders;
  • * Insufficient knowledge of Dutch language
  • * No informed consent

研究者

相似试验